# Medicamen Biotech Ltd-$ (MEDICAMEQ)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹266.85
Day Change: -2.77%
52W High: ₹454
52W Low: ₹220
Market Cap: ₹380 Cr

## Valuation
P/E: 48.05
P/B: 1.74
EPS: ₹5.83
Book Value: ₹161.11
Dividend Yield: 0%

## Returns
1Y Return: -34.04%

## Profitability
ROE: 0%
ROCE: 8.9%
Debt/Equity: 0.14
Revenue Growth: 5.1%
Profit Growth: -47.4%
EBITDA Margin: 10.95%
Operating Margin: 6.5%

## About
Medicamen Biotech Ltd-$ is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Medicamen Biotech Ltd-$ makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Announcement Under Regulation 30 (LODR) - Intimation Regarding Incorrect Event Disply On NSDL Portal
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-18T22:59:27.448Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:27.448Z
Quant Updated: 2026-05-18T22:59:27.448Z
Sentiment Updated: 2026-05-18T22:59:27.448Z
Financials Status: current
Financials Updated: 2026-05-18T22:31:58.642Z
Financials Last Attempt: 2026-05-18T22:31:58.642Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹162.55 Cr
Operating Profit: ₹12.38 Cr (OPM 7.62%)
Net Profit: ₹7.11 Cr
Tax: ₹3.32 Cr

## Annual P&L History
FY25: Rev ₹162.55Cr | PAT ₹7.11Cr | OPM 7.62%
FY24: Rev ₹179.31Cr | PAT ₹10.93Cr | OPM 9.7%
FY23: Rev ₹140.87Cr | PAT ₹14.84Cr | OPM 13.41%

## Balance Sheet (FY25)
Total Assets: ₹297.15 Cr
Total Liabilities: ₹84.1 Cr
Borrowings: ₹33.77 Cr
Cash: ₹3.76 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rajesh  Madan B. Pharma, Chief Executive Officer
- Chandan  Kumar, Chief Financial Officer
- Parul  Choudhary, Compliance Officer & Company Secretary
- Aneek  Gupta, Head of Pharmacovigilance & Operations
- Ashwani Kumar Sharma, Whole-Time Director

---
Source: rupiya.io/stocks/medicameq
Disclaimer: For research and education only. Not investment advice.